This microlearning activity is part of a case-based series designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving biomarker testing and treatment for NSCLC. This specific course focuses on biomarker testing guidelines and best practices for biomarker testing across stages of NSCLC.
Course topics include:
- Biomarkers for NSCLC therapies
- Clinical Staging and Biomarker Testing
- Testing Assays
- Summary of Current Guidelines
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
- Understand the significance of biomarker testing in the diagnosis and treatment of NSCLC
- Identify key biomarkers including EGFR, ALK, and PD-L1, and their roles in NSCLC therapies
- Describe the relationship between clinical staging and the selection of biomarker testing strategies
- Explain the current clinical guidelines for biomarker testing in NSCLC
Faculty
Haodong Xu
Director, Anatomic Pathology, Professor of Pathology, Internal Medicine, and Cardiovascular Medicine
Wake Forest University
Winston-Salem, NC
Faculty Disclosures
Haodong Xu has no financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .25 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line.
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.